SecBot SecBot
Home › SEC Filings › Press Releases

Press Releases

10,000+ reports analyzed by SecBot AI · browse by date or by stock
TickerTypeSentimentImpactSummaryDate
DERMPRESS-RELEASEbearish6/10Journey Medical reported Q1 2026 EPS of -$0.08, a 255.6% miss vs consensus of -$0.02, with revenue of $18.5M slightly abAug 12, 2026
DAIOPRESS-RELEASEbearish6/10Data I/O Corporation reported Q1 2026 EPS of -$0.21, a 425% miss versus the $0.04 consensus estimate, on revenue of $5.2Aug 12, 2026
USIOPRESS-RELEASEbullish7/10Usio reported Q1 2026 revenue of $23.7M (+19% YoY), in line with consensus, and GAAP EPS of $0.00, beating the consensusAug 12, 2026
BBGIPRESS-RELEASEbearish6/10Beasley Media Group reported Q2 2026 net revenue of $44.1M, down 16.8% YoY from $53.0M, and a GAAP net income of $84.3M Aug 12, 2026
HYPRESS-RELEASEneutral5/10No summary providedAug 12, 2026
LPLAPRESS-RELEASEbearish5/10LPL Financial reported Q2 2026 EPS of $5.84, a 2.2% miss versus consensus of $5.97, though revenue was not explicitly stAug 12, 2026
GNTPRESS-RELEASEneutral3/10GNT declared monthly cash distributions of $0.06 per share for October, November, and December 2026, continuing its poliAug 12, 2026
NXXTPRESS-RELEASEneutral1/10NextNRG, Inc. announced it will host a conference call on August 13, 2026 to discuss its Q2 2026 results.Aug 12, 2026
GGZPRESS-RELEASEneutral2/10The Gabelli Global Small and Mid Cap Value Trust declared a $0.21 per share quarterly cash distribution, payable SeptembAug 12, 2026
GGTPRESS-RELEASEneutral2/10The Gabelli Multimedia Trust (GGT) announced continuation of its monthly cash distribution policy at $0.22 per share quaAug 12, 2026
GLUPRESS-RELEASEneutral2/10The Gabelli Global Utility & Income Trust (GLU) declared monthly cash distributions of $0.11 per share for October, NoveAug 12, 2026
GDLPRESS-RELEASEneutral2/10The GDL Fund declared a $0.12 per share quarterly cash distribution, payable September 23, 2026 to shareholders of recorAug 12, 2026
ECFPRESS-RELEASEneutral3/10Ellsworth Growth and Income Fund Ltd. (ECF) declared a $0.22 per share quarterly cash distribution, a 16% increase from Aug 12, 2026
MNPRPRESS-RELEASEbullish6/10Monopar Therapeutics reported a Q2 2026 net loss of $5.3M ($0.62/share), wider than the $2.5M loss in Q2 2025, driven byAug 12, 2026
LVOPRESS-RELEASEbearish5/10LiveOne reported Q1 Fiscal 2027 revenue of $19.35M, essentially flat year-over-year ($19.21M), and a GAAP net loss of -$Aug 12, 2026
NEONPRESS-RELEASEneutral5/10No summary providedAug 12, 2026
FLYWPRESS-RELEASEneutral3/10Flywire announced an expanded partnership with Trustly to offer open banking payments in the U.S. and Canada, building oAug 12, 2026
APREPRESS-RELEASEneutral5/10Aprea Therapeutics reported Q2 2026 results with a net loss of $3.6M ($-0.07/share), widening from a $3.2M loss in Q2 20Aug 12, 2026
DYAIPRESS-RELEASEbearish7/10Dyadic International reported Q2 2026 revenue of $961,138, essentially flat year-over-year (-0.6%), and a net loss of $2Aug 12, 2026
EHLDPRESS-RELEASEbullish6/10Euroholdings reported Q2 2026 net revenues of $8.6M (up 195% YoY) and net income of $4.3M ($1.52 EPS), driven by a thirdAug 12, 2026
KNPRESS-RELEASEneutral3/10Knowles Corporation announced a manufacturing agreement with Elucent Medical to produce a smart surgical guidance deviceAug 12, 2026
LIQTPRESS-RELEASEbearish7/10LiqTech reported Q2 2026 revenue of $4.4M (down 12% YoY) and a net loss of $(3.1)M, missing consensus EPS of $(0.19) by Aug 12, 2026
HSDTPRESS-RELEASEneutral1/10Solana Company announced it will report its Q2 2026 results on August 14, 2026.Aug 12, 2026
ANTAPRESS-RELEASEneutral1/10Antalpha Platform Holding Company announced it will report its Q2 2026 results on August 19, 2026.Aug 12, 2026
PODCPRESS-RELEASEmixed5/10PodcastOne reported Q1 Fiscal 2027 revenue of $16.1M (+8% YoY), beating the $17.8M consensus, but GAAP EPS of -$0.05 misAug 12, 2026
IPSCPRESS-RELEASEbearish5/10Century Therapeutics reported Q2 2026 EPS of -$0.17, a 55.3% miss vs consensus of -$0.11, with no revenue. The company hAug 12, 2026
PYPDPRESS-RELEASEbullish7/10PolyPid reported Q2 2026 EPS of -$0.35, beating consensus of -$0.38 by 7.3%, with no revenue. The key catalyst is the FDAug 12, 2026
ALTPRESS-RELEASEneutral5/10Altimmune reported Q2 2026 net loss of $0.12 per share, beating consensus of -$0.13 by 7.7%, but this is a mechanical arAug 12, 2026
ADAGPRESS-RELEASEmixed6/10Adagene reported H1 2026 net loss of $16.4M, wider than $13.5M in H1 2025, with EPS of -$0.23 vs consensus -$0.08 (a 187Aug 12, 2026
BWAYPRESS-RELEASEbullish7/10BrainsWay reported Q2 2026 revenue of $17.1M (+35% YoY), EPS of $0.07 (GAAP), and raised FY 2026 revenue guidance to $68Aug 12, 2026
« Previous Page 136 of 334 Next »